These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1655539)

  • 21. The complex between a tissue inhibitor of metalloproteinases (TIMP-2) and 72-kDa progelatinase is a metalloproteinase inhibitor.
    Kolkenbrock H; Orgel D; Hecker-Kia A; Noack W; Ulbrich N
    Eur J Biochem; 1991 Jun; 198(3):775-81. PubMed ID: 1646720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gelatinase contributes to the degradation of glomerular basement membrane collagen by human neutrophils.
    Vissers MC; Winterbourn CC
    Coll Relat Res; 1988 Mar; 8(2):113-22. PubMed ID: 2837358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited proteolysis of C1-inhibitor by chymotrypsin-like proteinases.
    Schoenberger OL; Sprows JL; Schechter NM; Cooperman BS; Rubin H
    FEBS Lett; 1989 Dec; 259(1):165-7. PubMed ID: 2599103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mercurial activation of human PMN leucocyte type IV procollagenase (gelatinase).
    Triebel S; Bläser J; Reinke H; Knäuper V; Tschesche H
    FEBS Lett; 1992 Feb; 298(2-3):280-4. PubMed ID: 1312026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of cleavage site specificity of gelatinases A and B using collagenous peptides.
    Xia T; Akers K; Eisen AZ; Seltzer JL
    Biochim Biophys Acta; 1996 Apr; 1293(2):259-66. PubMed ID: 8620038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The latent collagenase and gelatinase of human polymorphonuclear neutrophil leucocytes.
    Murphy G; Bretz U; Baggiolini M; Reynolds JJ
    Biochem J; 1980 Nov; 192(2):517-25. PubMed ID: 6263256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary structure of the reactive site of human C1-inhibitor.
    Salvesen GS; Catanese JJ; Kress LF; Travis J
    J Biol Chem; 1985 Feb; 260(4):2432-6. PubMed ID: 3919001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A common neoepitope is created when the reactive center of C1-inhibitor is cleaved by plasma kallikrein, activated factor XII fragment, C1 esterase, or neutrophil elastase.
    de Agostini A; Patston PA; Marottoli V; Carrel S; Harpel PC; Schapira M
    J Clin Invest; 1988 Aug; 82(2):700-5. PubMed ID: 2457036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Degradation of C1-inhibitor by plasmin: implications for the control of inflammatory processes.
    Wallace EM; Perkins SJ; Sim RB; Willis AC; Feighery C; Jackson J
    Mol Med; 1997 Jun; 3(6):385-96. PubMed ID: 9234243
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.
    Ward RV; Hembry RM; Reynolds JJ; Murphy G
    Biochem J; 1991 Aug; 278 ( Pt 1)(Pt 1):179-87. PubMed ID: 1909113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transforming growth factor-beta and interleukin-1 modulate metalloproteinase expression by corneal stromal cells.
    Girard MT; Matsubara M; Fini ME
    Invest Ophthalmol Vis Sci; 1991 Aug; 32(9):2441-54. PubMed ID: 1651296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of cleavage by a Crotalus atrox alpha-proteinase fraction on the properties of C1-inhibitor.
    Patston PA; Qi M; Schifferli JA; Schapira M
    Toxicon; 1995 Jan; 33(1):53-61. PubMed ID: 7778129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The structural basis for neutrophil inactivation of C1 inhibitor.
    Pemberton PA; Harrison RA; Lachmann PJ; Carrell RW
    Biochem J; 1989 Feb; 258(1):193-8. PubMed ID: 2930506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elastase and metalloproteinase activities regulate soluble complement receptor 1 release.
    Sadallah S; Hess C; Miot S; Spertini O; Lutz H; Schifferli JA
    Eur J Immunol; 1999 Nov; 29(11):3754-61. PubMed ID: 10556832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase.
    Kinoshita T; Sato H; Takino T; Itoh M; Akizawa T; Seiki M
    Cancer Res; 1996 Jun; 56(11):2535-8. PubMed ID: 8653693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recombinant C1 inhibitor P5/P3 variants display resistance to catalytic inactivation by stimulated neutrophils.
    Eldering E; Huijbregts CC; Nuijens JH; Verhoeven AJ; Hack CE
    J Clin Invest; 1993 Mar; 91(3):1035-43. PubMed ID: 8450033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type I collagen degradation by mouse calvarial osteoblasts stimulated with 1,25-dihydroxyvitamin D-3: evidence for a plasminogen-plasmin-metalloproteinase activation cascade.
    Thomson BM; Atkinson SJ; McGarrity AM; Hembry RM; Reynolds JJ; Meikle MC
    Biochim Biophys Acta; 1989 Nov; 1014(2):125-32. PubMed ID: 2554972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2.
    Schwartz JD; Monea S; Marcus SG; Patel S; Eng K; Galloway AC; Mignatti P; Shamamian P
    J Surg Res; 1998 Apr; 76(1):79-85. PubMed ID: 9695744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9.
    Ochieng J; Fridman R; Nangia-Makker P; Kleiner DE; Liotta LA; Stetler-Stevenson WG; Raz A
    Biochemistry; 1994 Nov; 33(47):14109-14. PubMed ID: 7947821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The sequence of a cDNA encoding functional murine C1-inhibitor protein.
    Russell JA; Whaley K; Heaphy S
    Biochim Biophys Acta; 1997 May; 1352(2):156-60. PubMed ID: 9199246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.